Columbia News Updates

Delveinsight Business Research LLP

DelveInsight’s “Obesity Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Obesity Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Obesity market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Obesity: An Overview

Obesity is a chronic condition that affects more than one in three adults and about 17 percent of children and adolescents in the United States. More than one in three adults is overweight. Being overweight or obese increases your risk of type 2 diabetes, heart disease, stroke, fatty liver disease, kidney disease, and other health issues. Obesity is not just a cosmetic consideration. It is a chronic medical disease that can lead to diabetes, high blood pressure, and obesity-associated cardiovascular disease. Obesity is difficult to treat and has a high relapse rate.

Obesity Market Key Facts

• As per a survey from 2017-2018 by National Health and Nutrition Examination Survey (NHANES), the age-adjusted prevalence of obesity among U.S. adults was 42.4% in 2017–2018. It was observed that the prevalence was 40.0% among younger adults aged 20–39, 44.8% among middle-aged adults aged 40–59, and 42.8% among older adults aged 60 and over.

• According to Organization for Economic Co-operation and Development (2019), it is estimated that just under one in four adults in Germany are obese. As a result, Germans live on average 2.6 years less due to being overweight.

• According to the statistics from National Health Service (NHS) England (2020), most adults were being overweight or obese. Overall, 67% of men and 60% of women were classified as overweight or obese.

• As per DelveInsight, in 2021, the total prevalent cases of obesity in adults (>19 years) were 182.22 Million (M) and in children (5–19 years) were 7.85 million in the 7MM, which is expected to grow during the study period, i.e., 2019–2032.

Obesity Market

The dynamics of weight management in the obese and overweight population are anticipated to change as companies across the globe are thoroughly working toward developing new drug therapy options for managing this issue.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Obesity market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Obesity market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.

Obesity Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders. 

Obesity Epidemiology Segmentation

• Total diagnosed prevalent cases of Obesity/Overweight

• Total diagnosed prevalent cases of Obesity/Overweight segmented by gender

• Total diagnosed prevalent cases of Obesity/Overweight segmented by age 

• Total Prevalent Cases of Obesity/Overweight 

• Total treated cases of Obesity/Overweight segmented by therapies

Obesity Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Obesity market or expected to get launched during the study period. The analysis covers Obesity market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Obesity Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How Obesity Market Will Evolve by 2032 @ https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market

Obesity Therapeutics Analysis

Several options are available to lose weight, such as Dietary Modification, Behavior Modification, Exercise, Prescription weight-loss medication, and some kinds of surgeries. Medications are essential to the morbid obesity treatment process; however, certain weight-loss drugs can have serious side effects. Over the past few years, several therapies have been approved by US FDA for weight loss. 

To further strengthen the therapeutic approach to obesity management, globally, several key companies are actively working in the drug development segment.

• On October 6, 2022, Eli Lilly and Company (NYSE: LLY) announced that the US FDA had granted Fast Track designation to its investigation therapy, tirzepatide for the treatment of adults with obesity or overweight with weight-related comorbidities. 

• On September 28, 2022, Altimmune, Inc. (Nasdaq: ALT) announced the completion of the first dosing of all subjects in its Phase 2 MOMENTUM trial evaluating the safety and efficacy of pemvidutide in subjects with obesity or overweight.  

Some of the key companies in the Obesity Market include:

Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSirt Biopharma, Novartis, CSPC Baike (Shandong) Biopharmaceutical, Jiangsu HengRui Medicine, Carmot Therapeutics, Pfizer, Sciwind Biosciences, Empros Pharma and several others.

Obesity Therapies covered in the report include:

• BI 456906

• IBI362

• Semaglutide

• Tirzepatide

• PYY 1875

And many more

Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More:

https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Obesity Competitive Intelligence Analysis

4. Obesity Market Overview at a Glance

5. Obesity Disease Background and Overview

6. Obesity Patient Journey

7. Obesity Epidemiology and Patient Population (In US, EU5, and Japan)

8. Obesity Treatment Algorithm, Current Treatment, and Medical Practices

9. Obesity Unmet Needs

10. Key Endpoints of Obesity Treatment

11. Obesity Marketed Products

12. Obesity Emerging Drugs and Latest Therapeutic Advances

13. Obesity Seven Major Market Analysis

14. Attribute Analysis

15. Obesity Market Outlook (In US, EU5, and Japan)

16. Obesity Access and Reimbursement Overview

17. KOL Views on the Obesity Market

18. Obesity Market Drivers

19. Obesity Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF to Explore the Key Offerings of the Report:

https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Other Trending Healthcare Reports By DelveInsight

Anti-retropulsion Devices Market

“Anti-retropulsion Devices Market” research report provides comprehensive insights into the historic and forecasted market size, share, trends, and growth estimation for Anti-retropulsion Devices. It also covers the latest breakthroughs, collaboration, latest innovations, emerging devices, and key companies working in the global Anti-retropulsion Devices market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/